T-Cell Responses and T-Cell-Based Therapy in Acute Myeloid Leukemia

2025/11/17 by Zehan Huang, Ze-han Huang, Ran He · 1 voice
Immunology and Microbiology · Medicine · #Acute Myeloid Leukemia Research #CAR-T cell therapy research #Immunotherapy and Immune Responses

paper · doi:10.1007/s11596-025-00121-4

crossref issued 2025/11/17 · crossref published 2025/11/17 · crossref published-online 2025/11/17 · openalex created_date 2025/11/17 · openalex publication_date 2025/11/17 · crossref created 2025/11/17 · crossref published-print 2025/12/01 · crossref deposited 2025/12/29 · crossref indexed 2025/12/29 · openalex updated_date 2026/07/23

Citations

• NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
• IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia

Discussions

• This study explores T cell subsets in #AcuteMyeloidLeukemia and highlights #TCRT, #CART, and #CheckpointInhibitors as essential #Immunotherapies for achieving long term #DiseaseControl. #medsky To re [bsky, 0 points, 0 comments]